The ENCePP Steering Group has adopted the network's new three year work plan. The main goal during 2017 to 2019 will be to optimise ENCePP's input to regulatory decision-making throughout the product life-cycle. Particular focus will be on the development of methods in impact research and to identify enablers and barriers to measuring the impact of pharmacovigilance.
Related information:
Details
- Publication date
- 13 February 2017
- Author
- European Medicines Agency